ObjectiveTo determine patients’ self-reported preferences and expectations for outpatient upper gastrointestinal (UGI) endoscopy, including patients’ priorities in obtaining a satisfactory healthcare experience, preprocedure anxiety and its causes, and preferred staff roles.DesignA composite, dedicated endoscopy questionnaire was used. This included demographic information, validated Likert scale anxiety-related questions and a 15-point ranking scale of aspects of care (1=most important to satisfaction; 15=least important).Setting and patientsUnselected patients attending for an elective UGI endoscopy at two separate units were surveyed on randomly identified days.ResultsA total of 202 out of 254 patients agreed to participate (79.5%). The values identified as most important to patients included technical skill (2.8) and personal manner of the endoscopist (4.9) and the nurses and support staff (5.8), control of discomfort (5.6) and adequacy of the preprocedure explanation (5.8). The factors considered least important included noise levels (12.5), privacy (10.7) and cleanliness (8.7). Moderate to severe anxiety was recorded in half of the patient cohort, predominantly due to anticipation of pain or the results of the procedure. Most patients preferred the endoscopist to discuss the findings of the endoscopy but expressed no preferences regarding the preprocedure explanation.ConclusionPatients undergoing UGI endoscopy appear to highly prioritise aspects of care relating to interaction with the endoscopist and the procedure itself. Environmental factors are considered to have much less value. These findings may assist in service redesign around patient-centred care and the development of patient satisfaction surveys in endoscopy.
IntroductionA retrospective study evaluating the impact of the English national oesophageal and gastric cancer awareness campaign (26/01/2015-22/02/2015) on a large district general hospital (DGH). The campaign involved radio and television broadcasts advising medical assessment for dysphagia or persistent dyspepsia.MethodsData from all two week wait (2 ww) OG referrals triaged to gastroscopy (OGD) from January to July in 2014 and 2015, was audited retrospectively. The Somerset Cancer Register (SCR) database was used for data collection. Age and World Health Organisation (WHO) performance status, recorded at point of referral, was retrieved from the SCR.Number of referrals, cancer diagnoses, age, WHO performance status and treatment intent were compared between an identical 6 month period in 2014 and 2015. Formal statistical analysis was not carried out.ResultsThere was a 26% increase in 2 ww referrals from 2014 to 2015 (530 to 667) and 4% in non 2 ww referrals (477 to 496). The number and percentage (%yield) of OG cancer diagnoses from 2 ww referrals was 27 (5.0%) in 2014 compared to 32 (4.8%) in 2015. The number and percentage (%yield) of OG cancer diagnoses from routes other than 2 ww OG referral was 17 (3.6%) in 2014 compared to 26 (5.2%) in 2015. The mean and median age at diagnosis expressed in years was 77 and 79 (2014) compared with 69 and 75 (2015). Of OG cancer diagnoses, the treatment intent was considered potentially curative in 33% (2014) compared with 34% (2015). Percentage of patients recorded as WHO performance status 0 and 1 combined was 74% (2014) compared to 91% (2015). One year mortality data is not yet available due to early reporting.ConclusionThe 26% increase in 2 ww OG referrals is likely to be heavily influenced by the national OG awareness campaign, on the background of an 11% per annum increase in demand for diagnostic endoscopy services. Interestingly the percentage of cancer findings at OGD remained around 5% indicating that the increased diagnostic throughput has translated to OG cancer diagnoses. The mean and median age at diagnosis was 8 and 4 years lower respectively; this may indicate earlier patient directed self-referral to primary care with OG symptoms, suggesting that the campaign has reached its target audience. Unfortunately, there was not been an obvious increase in potentially curative OG cancer diagnoses; however, the younger group and better performance status may support more intense oncological therapy, leading to improved outcomes.Disclosure of InterestNone Declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.